Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel
出版年份 2014 全文链接
标题
Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel
作者
关键词
Germline genetic variability, Early breast cancer, Chemotherapy, Breast cancer-specific survival, Recurrence-free interval, Single nucleotide polymorphisms
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume 147, Issue 3, Pages 557-570
出版商
Springer Nature
发表日期
2014-08-29
DOI
10.1007/s10549-014-3105-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pre-adjuvant chemotherapy leukocyte count may predict the outcome for advanced gastric cancer after radical resection
- (2014) Dong Pei et al. BIOMEDICINE & PHARMACOTHERAPY
- Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors
- (2014) Alena M Pfeil et al. BMC CANCER
- Clinical Implications of Systemic Inflammatory Response Markers as Independent Prognostic Factors in Colorectal Cancer Patients
- (2014) Kwang Yeol Paik et al. Cancer Research and Treatment
- Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC)
- (2013) C. Vulsteke et al. ANNALS OF ONCOLOGY
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers
- (2012) O. Brouckaert et al. ANNALS OF ONCOLOGY
- Increased metastases are associated with inflammation and matrix metalloproteinase-9 activity at incision sites in a murine model of peritoneal dissemination of colorectal cancer
- (2012) In Kyu Lee et al. JOURNAL OF SURGICAL RESEARCH
- ABCC1polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia
- (2011) Agnes F. Semsei et al. CELL BIOLOGY INTERNATIONAL
- Physical and Psychosocial Recovery in the Year After Primary Treatment of Breast Cancer
- (2011) Patricia A. Ganz et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
- (2011) Henk Visscher et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing
- (2011) Joke Reumers et al. NATURE BIOTECHNOLOGY
- Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients
- (2010) Z. Sun et al. ANNALS OF ONCOLOGY
- Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients
- (2010) Ilaria Pastina et al. BMC CANCER
- Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide
- (2010) J Bray et al. BRITISH JOURNAL OF CANCER
- A Functional Polymorphism in the NAD(P)H Oxidase Subunit CYBA Is Related to Gene Expression, Enzyme Activity, and Outcome in Non-Hodgkin Lymphoma
- (2010) M. Hoffmann et al. CANCER RESEARCH
- Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients
- (2009) Marie-Christine Etienne-Grimaldi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Very low prevalence of XPD K751Q polymorphism and its association with XPD expression and outcomes of FOLFOX-4 treatment in Asian patients with colorectal carcinoma
- (2009) Jiun-I. Lai et al. CANCER SCIENCE
- Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21
- (2009) D Rossi et al. LEUKEMIA
- Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients
- (2009) A V Khrunin et al. PHARMACOGENOMICS JOURNAL
- Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer
- (2008) James J. Dignam et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer
- (2008) Rainer Fagerholm et al. NATURE GENETICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started